adamed laboratorios slu

ADAMED Laboratorios SLU

* Dedicated in body and mind

“Instead of a passive waiting for what future will bring us, we belive in a possibility of creating it.

From the very beggining…

This philosophy has been inspiring us till now. We hope it will be also yours from tomorrow.”

Adamed Spain – “a dream come true”

ADAMED Laboratorios S.L.U. (Spain) is going to be a dynamic and innovative pharmaceutical company focus on CNS specialists an CNS pathologies in order to create add-value services and high quality products that represents a

benefit for population.

the words (october 2008)

OBJECTIVES:

Adamed Spain

Young company (average experience: 12 years in Spanish Market)R&D Support of Adamed Poland Innovative beyond products…specialist and patients contactsSpecialized in SNC specialists (complicate Area)Gives high quality solutions Dynamic and FlexibleFocused but with expansion expectations

Characteristics:

Adamed Spain – “a dream come true”

Specialized in Specialist: Focus on CNS specialists (psychiatrist and neurologist) focus on:– Schizophrenia Units– Bipolar Disease Units– Addictions Units– Parkinson Units

Our identity: quality and add-value services– Products manufactured in Europe– Closing work with Scientific societies, be a referent on CNS market

FACTS:

Adamed ProductsPRODUCT MOLECULE LAUNCH DATE

Topiramate(Antiepileptic drug)

April 2009

Quetiapine (Antipsychotic drug)

April 2009

Lamotrigine(Antiepileptic- Mood Stabilaser)

June 2009

Venlafaxine(Dual Antidepressant)

May 2009

Pramipexol e(Antiparkinsonian drug)

Sept. 2010

Clozapine (Antipsychotic drug)

March 2011

Olanzapine (Antipsychotic drug)

25th of April 2011

Adamed Evolution since launch

142%142%

151%151%

Adamed Spain – “a dream come true”

Focus on CNS Specialist with a high positioning with the KOL of both societies.

Recognised high-cooperation with Health Authorities pharma company

Developing projects closed to medical societies:– Suicide Recommendations – SEP. SEPB- FEPSM– Fornes Project– Book for BD patients and family– Best in Class Awards for Neuro Specialist

Awards received:– Launching Acomicil: Diario Médico– Book for BD patients and family

FACTS:

Projects developed with CNS specialist

Academia de Semiología“Recommendations for preventing

and managing Suicidal behaviors”

ACO-TEXT Trial: Evaluating adherence to treatment sending daily SMS to patients withaddictions

Neuro Best in Class Awards

Adamed launching

Projects developed with CNS specialist

Strategic Plan

Consolidate Adamed as a reference company for CNS

Be a reference for the CNS specialists

Support for patients and their families with information programs

Simplicity and dynamism as a basis for the company strategy: – Working team– Pharma business, market and customer Knowledge– Value of well-done work

Objectives:

Adamed Spain belongs to Adamed Group

POLAND1986

SPAIN(september 2008)

Some data…

1.500 people working in Adamed PolandAPI, FP facilities (incl. Polfa and Agropharm adcquisitions)25 patents 475 salesforce / 100 people working in R&D150 M€ Polish market turnover after mergers / 20 M€ export salesIntroduced in many areas: cardio, CNS, gastro, respi, OTC…New chemical entities: oncology, diabetes, CNSPhilosophy: “From generic to innovative pharma”

History of innovation in Adamed

PRIORITY AREAS OF OUR PRIORITY AREAS OF OUR R &D:R &D:

Research ofInnovative drugs

Metabolic Diseases

Metabolic Platform

Cancer Diseases

Oncology Platform

NeuropsychiatryPlatform

CNS Diseases